| 2021 |
| 06/14 | 222 | 224 | 220 | 220 | -1.35% | 222,000 | 55億7201万 | 0% |
| 06/11 | 223 | 225 | 222 | 223 | +0.45% | 105,700 | 56億4800万 | +0.9% |
| 06/10 | 223 | 224 | 221 | 222 | -0.89% | 88,700 | 56億2267万 | +0.45% |
| 06/09 | 223 | 224 | 222 | 224 | +0.9% | 91,000 | 56億7332万 | +1.36% |
| 06/08 | 222 | 223 | 220 | 222 | +0.45% | 110,400 | 56億2267万 | 0% |
| 06/07 | 222 | 224 | 221 | 221 | -0.45% | 96,900 | 55億9734万 | -0.9% |
| 06/04 | 223 | 225 | 222 | 222 | -1.33% | 167,500 | 56億2267万 | -0.45% |
| 06/03 | 222 | 228 | 222 | 225 | +1.35% | 178,700 | 56億9865万 | +0.45% |
| 06/02 | 222 | 225 | 222 | 222 | 0% | 149,600 | 56億2267万 | -0.89% |
| 06/01 | 228 | 228 | 222 | 222 | -1.33% | 304,400 | 56億2267万 | -1.33% |
| 05/31 | 228 | 231 | 225 | 225 | -2.6% | 336,300 | 56億9865万 | 0% |
| 05/28 | 233 | 267 | 227 | 231 | +6.45% | 4,223,700 | 58億5061万 | +2.21% |
| 05/27 | 20:00 Beroni Groupとの業務提携に向けた覚書締結のお知らせ |
| 05/27 | 216 | 219 | 215 | 217 | +0.93% | 168,300 | 54億9603万 | -4.41% |
| 05/26 | 218 | 218 | 215 | 215 | -0.46% | 217,700 | 54億4538万 | -5.7% |
| 05/25 | 219 | 220 | 216 | 216 | -0.92% | 136,900 | 54億7070万 | -5.26% |
| 05/24 | 219 | 221 | 218 | 218 | -0.46% | 111,700 | 55億2136万 | -4.39% |
| 05/21 | 221 | 224 | 217 | 219 | -0.45% | 182,900 | 55億4669万 | -4.37% |
| 05/20 | 222 | 223 | 218 | 220 | -0.9% | 87,900 | 55億7201万 | -3.93% |
| 05/19 | 216 | 222 | 216 | 222 | +2.78% | 146,100 | 56億2267万 | -3.06% |
| 05/18 | 216 | 219 | 215 | 216 | +0.47% | 86,000 | 54億7070万 | -5.68% |
| 05/17 | 217 | 220 | 215 | 215 | -0.92% | 106,900 | 54億4538万 | -6.52% |
| 05/14 | 215 | 220 | 215 | 217 | +0.93% | 130,900 | 54億9603万 | -5.65% |
| 05/13 | 15:30 2021年12月期第1四半期決算短信〔日本基準〕(連結) |
| 05/13 | 219 | 221 | 215 | 215 | -1.83% | 212,500 | 54億4538万 | -6.93% |
| 05/12 | 223 | 229 | 219 | 219 | -2.23% | 320,500 | 55億4669万 | -5.19% |
| 05/11 | 228 | 228 | 223 | 224 | -0.44% | 153,900 | 56億7332万 | -3.03% |
| 05/10 | 222 | 229 | 222 | 225 | 0% | 266,000 | 56億9865万 | -3.02% |
| 05/07 | 17:05 特別損失の計上に関するお知らせ |
| 05/07 | 228 | 229 | 221 | 225 | -3.43% | 453,100 | 56億9865万 | -3.02% |
| 05/06 | 241 | 241 | 233 | 233 | -3.32% | 271,400 | 59億127万 | +0.43% |
| 04/30 | 247 | 255 | 240 | 241 | +0.42% | 559,400 | 61億389万 | +3.88% |
| 04/28 | 239 | 248 | 239 | 240 | +1.27% | 392,600 | 60億7856万 | +3.9% |
| 04/27 | 239 | 239 | 236 | 237 | +0.42% | 164,600 | 60億258万 | +2.6% |
| 04/26 | 235 | 239 | 235 | 236 | 0% | 154,000 | 59億7725万 | +2.61% |
| 04/23 | 16:00 再発防止策の進捗状況に関するお知らせ |
| 04/23 | 236 | 243 | 234 | 236 | +0.85% | 280,600 | 59億7725万 | +2.61% |
| 04/22 | 241 | 241 | 233 | 234 | -0.43% | 217,300 | 59億2660万 | +1.74% |
| 04/21 | 245 | 245 | 232 | 235 | -4.86% | 403,500 | 59億5192万 | +1.73% |
| 04/20 | 245 | 252 | 240 | 247 | -3.89% | 840,900 | 62億5585万 | +6.93% |
| 04/19 | 240 | 285 | 240 | 257 | +9.36% | 3,226,500 | 65億913万 | +11.74% |
| 04/16 | 221 | 235 | 220 | 235 | +6.33% | 288,600 | 59億5192万 | +2.62% |
| 04/15 | 222 | 224 | 220 | 221 | -0.9% | 124,200 | 55億9734万 | -3.49% |
| 04/14 | 225 | 225 | 222 | 223 | 0% | 98,100 | 56億4800万 | -2.62% |
| 04/13 | 222 | 224 | 217 | 223 | 0% | 368,000 | 56億4800万 | -2.62% |
| 04/12 | 226 | 226 | 221 | 223 | -1.33% | 137,200 | 56億4800万 | -3.04% |
| 04/09 | 226 | 228 | 225 | 226 | 0% | 129,700 | 57億2398万 | -1.31% |
| 04/08 | 228 | 230 | 226 | 226 | -0.88% | 126,700 | 57億2398万 | -1.74% |
| 04/07 | 229 | 231 | 226 | 228 | 0% | 108,200 | 57億7463万 | -1.72% |
| 04/06 | 231 | 232 | 226 | 228 | -0.87% | 196,600 | 57億7463万 | -2.15% |
| 04/05 | 227 | 232 | 227 | 230 | +1.32% | 164,300 | 58億2529万 | -2.13% |
| 04/02 | 229 | 231 | 227 | 227 | 0% | 123,200 | 57億4930万 | -4.22% |
| 04/01 | 228 | 231 | 227 | 227 | -1.73% | 125,100 | 57億4930万 | -5.02% |
| 03/31 | 230 | 232 | 227 | 231 | +1.76% | 117,300 | 58億5061万 | -4.15% |
| 03/30 | 226 | 232 | 226 | 227 | 0% | 197,600 | 57億4930万 | -6.58% |
| 03/29 | 15:00 新横浜かとうクリニックとの提携契約終了及び固定資産の譲渡並びに特別利益の計上について |
| 03/29 | 233 | 238 | 227 | 227 | -2.16% | 244,600 | 57億4930万 | -7.35% |
| 03/26 | 232 | 235 | 230 | 232 | +2.2% | 122,700 | 58億7594万 | -6.07% |
| 03/25 | 223 | 233 | 223 | 227 | +2.25% | 233,800 | 57億4930万 | -8.47% |
| 03/24 | 228 | 228 | 221 | 222 | -3.06% | 254,900 | 56億2267万 | -11.55% |
| 03/23 | 235 | 239 | 229 | 229 | -2.97% | 363,900 | 57億9996万 | -9.49% |
| 03/22 | 239 | 240 | 231 | 236 | -0.84% | 210,200 | 59億7725万 | -7.81% |
| 03/19 | 242 | 243 | 238 | 238 | -0.42% | 279,800 | 60億2791万 | -7.75% |
| 03/18 | 237 | 241 | 237 | 239 | 0% | 163,900 | 60億5323万 | -8.08% |
| 03/17 | 230 | 239 | 228 | 239 | +2.14% | 434,600 | 60億5323万 | -8.78% |
| 03/16 | 232 | 243 | 232 | 234 | +1.74% | 557,500 | 59億2660万 | -11.7% |
| 03/15 | 229 | 239 | 227 | 230 | +1.32% | 344,400 | 58億2529万 | -13.86% |
| 03/12 | 230 | 231 | 226 | 227 | -0.87% | 300,200 | 57億4930万 | -15.93% |
| 03/11 | 230 | 234 | 224 | 229 | +0.88% | 408,400 | 57億9996万 | -15.81% |
| 03/10 | 231 | 232 | 221 | 227 | -2.99% | 872,500 | 57億4930万 | -17.45% |
| 03/09 | 213 | 257 | 213 | 234 | +9.86% | 3,419,800 | 59億2660万 | -15.52% |
| 03/08 | 15:00 すい臓がんに対する樹状細胞ワクチンの医師主導治験における期間延長に伴う製造販売承認申請時期の遅延の見込みについて(経過情報) |
| 03/08 | 179 | 218 | 178 | 213 | -16.47% | 5,519,600 | 53億9472万 | -23.66% |
| 03/06 | 11:10 一部報道について |
| 03/05 | 256 | 257 | 245 | 255 | -1.92% | 494,900 | 64億5847万 | -9.89% |
| 03/04 | 268 | 268 | 256 | 260 | 0% | 399,200 | 65億8511万 | -8.77% |
| 03/03 | 270 | 273 | 255 | 260 | -5.11% | 819,700 | 65億8511万 | -9.09% |
| 03/02 | 278 | 280 | 270 | 274 | -1.44% | 319,200 | 69億3969万 | -4.86% |
| 03/01 | 276 | 280 | 273 | 278 | +1.09% | 193,300 | 70億4100万 | -3.81% |
| 02/26 | 18:00 役員人事に関するお知らせ |
| 02/26 | 278 | 287 | 275 | 275 | -1.43% | 505,400 | 69億6502万 | -5.5% |
| 02/25 | 278 | 293 | 276 | 279 | +0.72% | 506,000 | 70億6633万 | -4.45% |
| 02/24 | 280 | 287 | 276 | 277 | -1.77% | 281,100 | 70億1567万 | -5.46% |
| 02/22 | 275 | 288 | 272 | 282 | +3.68% | 637,300 | 71億4231万 | -4.08% |
| 02/19 | 270 | 274 | 266 | 272 | 0% | 395,600 | 68億8904万 | -8.11% |
| 02/18 | 279 | 282 | 272 | 272 | -3.55% | 546,500 | 68億8904万 | -8.42% |
| 02/17 | 278 | 284 | 263 | 282 | -0.7% | 847,900 | 71億4231万 | -5.69% |
| 02/16 | 292 | 292 | 282 | 284 | -2.74% | 806,500 | 71億9296万 | -5.33% |
| 02/15 | 18:00 監査等委員である取締役1名に対する辞任勧告の決議について |
| 02/15 | 16:30 業績の前期実績値との差異及び特別利益と特別損失の計上に関するお知らせ |
| 02/15 | 16:30 2020年12月期決算短信〔日本基準〕(連結) |
| 02/15 | 296 | 296 | 290 | 292 | -1.68% | 451,500 | 73億9558万 | -3.95% |
| 02/12 | 296 | 299 | 292 | 297 | +0.34% | 396,600 | 75億2222万 | -3.26% |
| 02/10 | 296 | 301 | 292 | 296 | +1.02% | 577,800 | 74億9689万 | -3.9% |
| 02/09 | 297 | 298 | 291 | 293 | -1.01% | 357,300 | 74億2091万 | -4.56% |
| 02/08 | 294 | 302 | 293 | 296 | +0.68% | 503,200 | 74億9689万 | -2.95% |
| 02/05 | 295 | 298 | 291 | 294 | +0.68% | 384,500 | 74億4624万 | -2.65% |
| 02/04 | 292 | 297 | 289 | 292 | 0% | 291,300 | 73億9558万 | -2.67% |
| 02/03 | 297 | 304 | 286 | 292 | -0.68% | 909,200 | 73億9558万 | -2.01% |
| 02/02 | 281 | 300 | 279 | 294 | +3.52% | 944,400 | 74億4624万 | -1.34% |
| 02/01 | 290 | 292 | 277 | 284 | -3.07% | 758,800 | 71億9296万 | -5.02% |
| 01/29 | 298 | 304 | 290 | 293 | -1.01% | 690,200 | 74億2091万 | -2.33% |
| 01/28 | 298 | 299 | 294 | 296 | -1.99% | 523,500 | 74億9689万 | -1.66% |
| 01/27 | 300 | 303 | 298 | 302 | -0.33% | 514,200 | 76億4886万 | 0% |
| 01/26 | 307 | 308 | 299 | 303 | -0.66% | 577,400 | 76億7418万 | 0% |
| 01/25 | 301 | 307 | 301 | 305 | -0.65% | 569,300 | 77億2484万 | 0% |
| 01/22 | 310 | 311 | 305 | 307 | -0.32% | 359,200 | 77億7549万 | +0.33% |
| 01/21 | 306 | 310 | 304 | 308 | +0.98% | 532,000 | 78億82万 | -0.32% |
| 01/20 | 310 | 310 | 304 | 305 | -0.33% | 483,300 | 77億2484万 | -2.56% |
| 01/19 | 308 | 314 | 304 | 306 | -0.33% | 579,000 | 77億5017万 | -3.47% |
| 01/18 | 305 | 312 | 296 | 307 | -3.15% | 1,123,900 | 77億7549万 | -4.66% |
| 01/12 | 22:40 (開示事項の経過報告)「第三者割当により発行される新株式の募集」及び「子会社の異動を伴う株式譲渡」の経過報告について |
